Market Entry - Adjuvant Industry in Malaysia: Analysis of Growth, Trends and Progress (2020 - 2025)

Looking to buy the report?

About the Market

Increase in the prevalence of cancer, growing reimbursement initiatives by governments and insurance companies covering treatment for cancer, with growth in preference for the future prevention of cancer are some of the major drivers of this market. The overall market for oncology adjuvants is classified on the basis of applications such as chemotherapy, radiotherapy, immunotherapy etc. By diseases which are treated through adjuvants, this market is classified into breast cancer, colorectal cancer, sarcoma, Hodgkin’s lymphoma, glioblastoma, lung cancer, prostate cancer, and ovarian cancer. North America, followed by Europe dominates the global market for breast cancer treatment, due to increasing incidence of cancer cases and technological advancement in the region. Some of the market players in this industry include pharmaceutical manufacturers such as Amgen Inc., Eli Lilly Co., BMS, Biogen, AstraZeneca PLC, Sanofi, and Pfizer Inc.

About the Geography

Malaysia is a southeast Asian country with a democratic constitutional monarchy government. It is the fifth largest recipient of FDI in Asia with most of the investment in the manufacturing, finance, mining and distribution sectors. Malaysia has 16 bilateral trade agreements, is a part of ASEAN and WTO, and is currently negotiating a Malaysia-European Free Trade Agreement.

Malaysia is located close to major Asia-Pacific markets and companies investing in Malaysia find it a cost-effective gateway to Asian markets. It has a well-developed financial sector, English-speaking majority, educated workforce, and follows high standards of business and legal practices. The government has a provided many incentives to encourage FDI like liberalizing expatriate employment regime and MSC program, which was launched in 2003 to extend tax exemption from 10-15 years for new technology companies and from 5-10 years for priority companies. It has not been able to generate more foreign investments due to bureaucracy, shortage of skilled workers, and the governments’ policies favoring indigenous Malaysians.

A strong financial sector, developed infrastructure, significant resources, competitive costs, and liberal and transparent investment policies make Malaysia an ideal destination for foreign investment.

 

Component Name

Unit

GDP (USD billion)

296

GDP Annual Growth Rate

4

GDP Per Capita

10877

Unemployment Rate

3.5

Wages

530.898

Inflation Rate

1.5

Consumer Price Index (CPI)

116

Interest Rate

3

Loans to Private Sector (USD billion)

381.399

Balance of Trade (USD billion)

2.022

Business Confidence

106

Manufacturing PMI (Index Points)

48.6 Index Points

Ease of Doing Business

18

Competitiveness Rank

25

Corruption Rank

54

Consumer Confidence

78.5

Consumer Spending (USD billion)

34.16

Bank Lending Rate (Consumers)

4.46

Corporate Tax Rate

25

Sales Tax Rate

6

 

The Market Entry Series

Exploring global markets is now recognized as the shortest way to ensure high time to efficiency conversion, when trying to expand revenues past domestic markets, for firms both large and small. Our market entry series, priced suitably low contains the essentials of all the parameters (Refer: Table of Contents) you must be apprised of before you can have a well informed contemplation of a business opportunity in your choice of industry, in your choice of geography.

1. Introduction

                1.1 Scope of the Report

                1.2 Regional Analysis

                                1.2.1 PESTLE Analysis

                                1.2.2 Analysis of Ease of Doing Business

2. Market Dynamics

                2.1 Drivers

                2.2 Restraints

                2.3 Opportunities

3. Market Demand Analysis

                3.1 Socio-Economic Segmentation

                3.2 Demographic Strengths & Weaknesses

                3.3 Spending Patterns

                3.4 Target Market Identification

4. Market Size of Adjuvant Industry (USD millions)

                4.1 By Types of Inorganic Compounds

                4.2 By Bacterial Products

5. Market Entry

                5.1 Market Entry: The Strategy

                                5.1.1 Types of Entry Modes, by Market Entry Objectives

                                5.1.2 Competition Analysis

                                                5.1.2.1 Market Share

                                                5.1.2.2 Strategies Adopted, Recent Events 

                                5.1.3 Pricing Strategy

                                5.1.4 Supply Chain Analysis

                                                5.1.4.1 Trade (Import-Export Analysis)

                                                5.1.4.2 Distribution Network & Retail Analysis

                5.2 Market Entry: The Administration

                                5.2.1 How to Register a Company (Flowchart)

                                5.2.2 Registration Processes 

                                                5.2.2.1 Ministries Involved

                                                5.2.2.2 Criteria and Conditions

                                5.2.3 List of Forms & Documents

                                5.2.4 Product Control Guidelines specified by the Government

6. Sources

7. Disclaimer

Looking to buy the report?

Need a report that reflects how COVID-19 has impacted this market and its growth?

Looking to customize report?

Email

Message

By submitting, you confirm that you agree to our privacy policy